http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2013100561-A4
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cf32b60391b469c41e86c353437f5751 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-137 |
| filingDate | 2013-04-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2013-05-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b7e389678839819fe874a6a69054bc90 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3ee8ac22cf1d2266a0ea79f505130b97 |
| publicationDate | 2013-05-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | AU-2013100561-A4 |
| titleOfInvention | Compositions Comprising Sphingosine 1 Phosphate (S1P) Receptor Modulators |
| abstract | Abstract The present invention relates to stable compositions comprising a sphingosine 1 phosphate (S1P) receptor modulator, suitable for use as a dosage form. The SIP receptor modulators are typically sphingosine analogues,.such as 2-substituted 2-amino- propane 1,3-diol or 2-amino-propanol derivatives, e. g. a compound comprising a group of formula. |
| priorityDate | 2007-10-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 173.